Premium
Kiniksa Pharmaceuticals International PLC (KNSA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Dr. Barry D. QuartIndependent Director | 2,80k | 0,00 | Derivative Exercise and Retained Stock | - | 15,35k | 22,31% |
| 2026-05-29 | Ms. Kimberly J. PopovitsIndependent Director | 2,80k | 0,00 | Derivative Exercise and Retained Stock | - | 15,35k | 22,31% |
| 2026-06-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | 900,00k | 0,00 | Derivative Exercise and Retained Stock | - | 1,14M | 378,53% |
| 2026-05-29 | Ms. Tracey L. McCainIndependent Director | 2,80k | 0,00 | Derivative Exercise and Retained Stock | - | 15,35k | 22,31% |
| 2026-05-29 | Mr. Thomas R. MalleyIndependent Director | 2,80k | 0,00 | Derivative Exercise and Retained Stock | - | 15,35k | 22,31% |
| 2026-05-29 | Dr. Richard S. LevyIndependent Director | 2,80k | 0,00 | Derivative Exercise and Retained Stock | - | 21,96k | 14,61% |
| 2026-05-29 | Mr. Gordon Bradley ColeIndependent Director | 2,80k | 0,00 | Derivative Exercise and Retained Stock | - | 15,35k | 22,31% |
| 2026-05-01 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -58,42k | 2,53M | Derivative Exercise and Sale | 10,36 - 54,04 | 65,62k | - |
| 2026-05-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | -48,57k | 1,12M | Derivative Exercise and Sale | 30,93 - 54,02 | 237,76k | - |
| 2026-04-28 | Mr. Sanj K. PatelCEO & Chairman of the Board | -508,34k | 19,58M | Derivative Exercise and Sale | 10,36 - 54,02 | 237,76k | - |
| 2026-04-28 | Dr. Barry D. QuartIndependent Director | -13,10k | 468,55k | Derivative Exercise and Sale | 14,33 - 50,10 | 12,55k | - |
| 2026-04-09 | Mr. Michael R. MegnaSenior VP & CAO | -6,63k | 309,32k | Automatic Disposition | 46,69 | 27,42k | -19,46% |
| 2026-04-09 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -1,70k | 79,51k | Automatic Disposition | 46,69 | 12,03k | -12,40% |
| 2026-04-07 | Mr. Eben TessariConsultant | 1,88k | 0,00 | Derivative Exercise and Retained Stock | - | 23,13k | 8,85% |
| 2026-04-07 | Mr. Eben TessariConsultant | -846,00 | 41,40k | Derivative Exercise and Sale | 48,94 | 23,13k | - |
| 2026-04-07 | Mr. Mark A. RagosaExec. VP & CFO | 1,39k | 0,00 | Derivative Exercise and Retained Stock | - | 16,15k | 9,42% |
| 2026-04-07 | Mr. Mark A. RagosaExec. VP & CFO | -1,30k | 63,77k | Derivative Exercise and Sale | 48,94 | 16,15k | - |
| 2026-04-07 | Mr. Sanj K. PatelCEO & Chairman of the Board | -4,83k | 236,43k | Sale to Issuer | 48,94 | 237,76k | -1,99% |
| 2026-04-06 | Mr. Sanj K. PatelCEO & Chairman of the Board | -7,28k | 288,57k | Derivative Exercise and Sale | 10,36 - 50,01 | 237,76k | - |
| 2026-04-07 | Mr. Sanj K. PatelCEO & Chairman of the Board | 9,99k | 0,00 | Derivative Exercise and Retained Stock | - | 237,76k | 4,39% |
| 2026-04-07 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | 1,29k | 0,00 | Derivative Exercise and Retained Stock | - | 65,62k | 2,00% |
| 2026-04-07 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -1,21k | 59,12k | Derivative Exercise and Sale | 48,94 | 65,62k | - |
| 2026-04-06 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -2,37k | 114,99k | Automatic Disposition | 48,58 | 13,73k | -14,70% |
| 2026-04-07 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -774,00 | 37,88k | Derivative Exercise and Sale | 48,94 | 13,73k | - |
| 2026-04-07 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | 1,70k | 0,00 | Derivative Exercise and Retained Stock | - | 13,73k | 14,16% |
| 2026-04-07 | Mr. Michael R. MegnaSenior VP & CAO | -1,67k | 79,87k | Derivative Exercise and Sale | 1,00 - 48,94 | 34,04k | - |
| 2026-04-07 | Mr. Michael R. MegnaSenior VP & CAO | 2,27k | 2,27k | Derivative Exercise and Retained Stock | 1,00 | 34,04k | 7,13% |
| 2026-04-06 | Dr. Barry D. QuartIndependent Director | -6,90k | 246,16k | Derivative Exercise and Sale | 14,33 - 50,00 | 12,55k | - |
| 2026-04-01 | Mr. Eben TessariConsultant | 4,22k | 0,00 | Derivative Exercise and Retained Stock | - | 21,25k | 24,77% |
| 2026-04-01 | Mr. Eben TessariConsultant | -1,76k | 84,52k | Derivative Exercise and Sale | 48,13 | 21,25k | - |
| 2026-04-01 | Mr. Mark A. RagosaExec. VP & CFO | 2,68k | 0,00 | Derivative Exercise and Retained Stock | - | 14,76k | 22,15% |
| 2026-04-01 | Mr. Mark A. RagosaExec. VP & CFO | -2,51k | 120,81k | Derivative Exercise and Sale | 48,13 | 14,76k | - |
| 2026-04-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | -10,31k | 496,36k | Derivative Exercise and Sale | 48,13 | 232,60k | - |
| 2026-04-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | 11,01k | 0,00 | Derivative Exercise and Retained Stock | - | 232,60k | 4,97% |
| 2026-04-01 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 64,33k | 4,91% |
| 2026-04-01 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -2,82k | 135,77k | Derivative Exercise and Sale | 48,13 | 64,33k | - |
| 2026-04-01 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | 4,10k | 0,00 | Derivative Exercise and Retained Stock | - | 14,40k | 39,85% |
| 2026-04-01 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -1,71k | 82,11k | Derivative Exercise and Sale | 48,13 | 14,40k | - |
| 2026-04-01 | Mr. Michael R. MegnaSenior VP & CAO | 4,36k | 0,00 | Derivative Exercise and Retained Stock | - | 31,78k | 15,90% |
| 2026-04-01 | Mr. Michael R. MegnaSenior VP & CAO | -3,21k | 154,26k | Derivative Exercise and Sale | 48,13 | 31,78k | - |
| 2026-03-09 | Mr. Mark A. RagosaExec. VP & CFO | -36,72k | 926,35k | Derivative Exercise and Sale | 17,76 - 46,24 | 12,09k | - |
| 2026-03-02 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -40,00k | 1,38M | Derivative Exercise and Sale | 10,36 - 45,92 | 61,32k | - |
| 2026-02-10 | Dr. Barry D. QuartIndependent Director | -2,80k | 82,68k | Derivative Exercise and Sale | 15,47 - 45,00 | 12,55k | - |
| 2026-02-09 | Mr. Mark A. RagosaExec. VP & CFO | -10,85k | 315,84k | Derivative Exercise and Sale | 12,97 - 43,72 | 12,09k | - |
| 2026-02-09 | Mr. Mark A. RagosaExec. VP & CFO | -7,00k | 306,04k | Automatic Disposition | 43,72 | 12,09k | -36,68% |
| 2026-02-02 | Dr. Barry D. QuartIndependent Director | -15,96k | 474,73k | Derivative Exercise and Sale | 15,47 - 45,27 | 12,55k | - |
| 2026-02-01 | Dr. Richard S. LevyIndependent Director | 683,00 | 0,00 | Derivative Exercise and Retained Stock | - | 19,16k | 3,70% |
| 2026-01-08 | Mr. Mark A. RagosaExec. VP & CFO | -12,00k | 502,68k | Automatic Disposition | 41,89 | 19,09k | -38,60% |
| 2025-12-15 | Dr. Barry D. QuartIndependent Director | -20,13k | 627,02k | Derivative Exercise and Sale | 10,36 - 41,51 | 12,55k | - |
| 2025-12-15 | Mr. Eben TessariConsultant | -6,00k | 196,38k | Derivative Exercise and Sale | 8,83 - 41,56 | 16,67k | - |
| 2025-12-15 | Mr. Eben TessariConsultant | -6,05k | 251,35k | Automatic Disposition | 41,56 | 16,67k | -26,63% |
| 2025-12-08 | Mr. Mark A. RagosaExec. VP & CFO | -42,84k | 1,29M | Derivative Exercise and Sale | 10,76 - 41,49 | 31,09k | - |
| 2025-11-26 | Mr. Eben TessariConsultant | -200,00 | 4,00k | Derivative Exercise and Sale | 22,89 - 42,89 | 22,71k | - |
| 2025-11-17 | Mr. Eben TessariConsultant | -6,50k | 210,27k | Derivative Exercise and Sale | 8,83 - 41,30 | 22,71k | - |
| 2025-11-17 | Mr. Eben TessariConsultant | -5,97k | 246,56k | Automatic Disposition | 41,30 | 22,71k | -20,81% |
| 2025-11-12 | Mr. Sanj K. PatelCEO & Chairman of the Board | -171,79k | 0,00 | Other Disposition | - | 221,59k | -43,67% |
| 2025-11-12 | Mr. Mark A. RagosaExec. VP & CFO | -19,90k | 199,20k | Derivative Exercise and Sale | 30,93 - 40,94 | 31,09k | - |
| 2025-10-31 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -82,54k | 2,52M | Derivative Exercise and Sale | 3,80 - 37,14 | 61,32k | - |
| 2025-10-28 | Mr. Mark A. RagosaExec. VP & CFO | -100,00 | 1,01k | Derivative Exercise and Sale | 30,93 - 41,00 | 31,09k | - |
| 2025-10-20 | Mr. Sanj K. PatelCEO & Chairman of the Board | -257,97k | 9,04M | Derivative Exercise and Sale | 3,80 - 39,32 | 221,59k | - |
| 2025-10-20 | Mr. Michael R. MegnaSenior VP & CAO | -39,44k | 1,07M | Derivative Exercise and Sale | 10,76 - 39,31 | 27,05k | - |
| 2025-10-20 | Mr. Michael R. MegnaSenior VP & CAO | -11,06k | 434,57k | Automatic Disposition | 39,31 | 27,05k | -29,01% |
| 2025-10-04 | Mr. Michael R. MegnaSenior VP & CAO | 90,00 | 0,00 | Derivative Exercise and Retained Stock | - | 38,10k | 0,24% |
| 2025-10-04 | Mr. Michael R. MegnaSenior VP & CAO | -85,00 | 3,27k | Derivative Exercise and Sale | 38,49 | 38,10k | - |
| 2025-09-29 | Mr. Eben TessariConsultant | -42,00k | 857,22k | Derivative Exercise and Sale | 17,92 - 38,33 | 34,55k | - |
| 2025-09-15 | Mr. Eben TessariConsultant | -6,50k | 179,53k | Derivative Exercise and Sale | 8,83 - 36,45 | 34,55k | - |
| 2025-09-15 | Mr. Eben TessariConsultant | -9,90k | 361,05k | Automatic Disposition | 36,45 - 37,00 | 34,55k | -22,27% |
| 2025-09-04 | Mr. Eben TessariConsultant | -98,66k | 1,98M | Derivative Exercise and Sale | 15,50 - 35,66 | 44,45k | - |
| 2025-09-04 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -3,52k | 124,40k | Automatic Disposition | 35,31 | 9,42k | -27,23% |
| 2025-09-01 | Mr. Eben TessariConsultant | 8,21k | 0,00 | Derivative Exercise and Retained Stock | - | 44,45k | 22,65% |
| 2025-09-03 | Mr. Eben TessariConsultant | -15,09k | 301,82k | Derivative Exercise and Sale | 15,50 - 35,50 | 44,45k | - |
| 2025-09-01 | Mr. Eben TessariConsultant | -3,97k | 133,77k | Sale to Issuer | 33,49 - 34,28 | 44,45k | -8,20% |
| 2025-09-01 | Mr. Michael R. MegnaSenior VP & CAO | 9,63k | 0,00 | Derivative Exercise and Retained Stock | - | 38,01k | 33,92% |
| 2025-09-03 | Mr. Michael R. MegnaSenior VP & CAO | -11,00k | 186,12k | Derivative Exercise and Sale | 17,92 - 34,84 | 38,01k | - |
| 2025-09-01 | Mr. Michael R. MegnaSenior VP & CAO | -4,66k | 156,26k | Sale to Issuer | 33,49 - 34,28 | 38,01k | -10,91% |
| 2025-09-01 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | 3,52k | 0,00 | Derivative Exercise and Retained Stock | - | 12,94k | 37,42% |
| 2025-09-01 | Mr. Ross Michael MoatExec. VP, COO & Principal Operating Officer | -3,30k | 110,90k | Derivative Exercise and Sale | 33,49 - 34,28 | 12,94k | - |
| 2025-09-01 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | 3,92k | 0,00 | Derivative Exercise and Retained Stock | - | 61,32k | 6,83% |
| 2025-09-01 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -3,68k | 123,77k | Derivative Exercise and Sale | 33,49 - 34,28 | 61,32k | - |
| 2025-09-01 | Mr. Mark A. RagosaExec. VP & CFO | 4,08k | 0,00 | Derivative Exercise and Retained Stock | - | 31,09k | 15,09% |
| 2025-09-01 | Mr. Mark A. RagosaExec. VP & CFO | -3,82k | 128,64k | Derivative Exercise and Sale | 33,49 - 34,28 | 31,09k | - |
| 2025-09-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | 15,12k | 0,00 | Derivative Exercise and Retained Stock | - | 221,59k | 7,32% |
| 2025-09-01 | Mr. Sanj K. PatelCEO & Chairman of the Board | -14,16k | 476,73k | Derivative Exercise and Sale | 33,49 - 34,28 | 221,59k | - |
| 2025-08-18 | Mr. Eben TessariConsultant | -6,50k | 162,11k | Derivative Exercise and Sale | 8,83 - 33,77 | 40,22k | - |
| 2025-08-18 | Mr. Eben TessariConsultant | -9,70k | 327,64k | Automatic Disposition | 33,77 - 34,44 | 40,22k | -19,43% |
| 2025-08-12 | Mr. Thomas R. MalleyIndependent Director | -177,77k | 4,04M | Derivative Exercise and Sale | 1,86 - 33,32 | 12,55k | - |
| 2025-08-06 | Dr. John F. PaoliniExec. VP & Chief Medical Officer | -29,33k | 843,09k | Derivative Exercise and Sale | 3,80 - 32,55 | 57,40k | - |
| 2025-08-05 | Mr. Eben TessariConsultant | -138,61k | 3,02M | Derivative Exercise and Sale | 10,36 - 33,90 | 49,92k | - |
| 2025-08-04 | Mr. Mark A. RagosaExec. VP & CFO | -18,89k | 188,89k | Derivative Exercise and Sale | 22,89 - 32,89 | 27,01k | - |
| 2025-08-04 | Mr. Michael R. MegnaSenior VP & CAO | -17,00k | 286,11k | Derivative Exercise and Sale | 15,52 - 32,35 | 33,04k | - |
| 2025-07-30 | Ms. Kimberly J. PopovitsIndependent Director | -64,51k | 1,16M | Derivative Exercise and Sale | 10,36 - 29,90 | 12,55k | - |
| 2025-07-14 | Mr. Eben TessariConsultant | -6,50k | 129,29k | Derivative Exercise and Sale | 8,83 - 28,72 | 49,16k | - |
| 2025-07-14 | Mr. Eben TessariConsultant | -12,40k | 356,13k | Automatic Disposition | 28,72 | 49,16k | -20,14% |
| 2025-07-01 | Dr. Richard S. LevyIndependent Director | 1,10k | 0,00 | Derivative Exercise and Retained Stock | - | 18,47k | 6,34% |
| 2025-06-16 | Mr. Eben TessariConsultant | -6,50k | 126,43k | Derivative Exercise and Sale | 8,83 - 28,28 | 61,56k | - |
| 2025-06-16 | Mr. Eben TessariConsultant | -10,80k | 305,42k | Automatic Disposition | 28,28 | 61,56k | -14,92% |
| 2025-06-09 | Dr. Barry D. QuartIndependent Director | -27,45k | 728,70k | Derivative Exercise and Sale | 3,80 - 30,39 | 12,55k | - |
| 2025-06-09 | Mr. Eben TessariConsultant | -70,87k | 1,43M | Derivative Exercise and Sale | 10,36 - 30,51 | 72,36k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
